There were challenges in sample collection and transportation. Early HIV screening during pregnancy and PMTCT service should be strengthened.
INTRODUCTION
Children bear a heavy burden of HIV infection (1, 2) . In 2009 alone, 370,000 infants and children were newly infected of which 260,000 died. Children make up approximately of 7 percent of the total number of people living with HIV worldwide. In the same year, fewer than 200,000 children living with HIV received antiretroviral treatment. Further, those on Highly Active AntiRetroviral Treatment (HAART) often receive it too late for the median age of five and nine years old (2) .
Globally in 2009, there were 33.3 million adults and children estimated to live with HIV/AIDS. Two and half million were infants and children living with HIV/AIDS of which approximately 90% were in sub-Saharan Africa. When infants and children with HIV are failed to take HAART, half of them will be die by the age of two years and three fourth will die within five years (1) . HIV testing from DBS using DNA PCR testing makes a definitive diagnosis in children below 18 months. This solves confusion of HIV test with persistence of maternal antibodies until this age (3) . In Ethiopia, by January 2009, Early Infant Diagnosis (EID) began in 58 hospitals and 23 health centers. In the same year, the number of infants and children tested almost doubled from 692 to 1340. Infants and children referred from PMTCT (Prevention of Mother to Child Transmission) and ART clinics, over the age of six weeks and below 12 months, and at some sites, below 18 months were tested (2) . Despite these efforts , there still are challenges such as limited access to EID, limited trained staff, very few sample collection facilities, inadequate transportation and poor sample storage system, limited number of laboratories capable of performing DNA PCR and few linkages for HIVinfected infants and children to ART clinics (2) .
METHODS

Study design and study participants:
A descriptive hospital based cross-sectional study was conducted in 2013 from March to May in two referral hospitals (Jimma University Teaching Hospital and St. Luke Referral Hospital) by giving pediatric Anti-Retroviral Treatments in Ethiopia. The study population included all registered HIVexposed infants and children from records of 2009 to 2011. Sample size and sampling procedure: In the two hospitals, between 2009 and 2011, there were 150 registered HIV-exposed infants and children whose HIV statuses were identified through DNA PCR by the regional laboratory. Then, study participants were identified at institution level based on set inclusion and exclusion criteria. The inclusion criteria were HIV-exposed infants and children < 18 months old, who were registered and screened within 2009 to 2011 in two hospitals. Twelve (12) HIV-exposed infants and children with no records on HIV status, treatment and mortality status and turnaround time status from registration book and computer data bases were excluded. As a result, data of only 138 (61 from St. Luke Referral Hospital and 77 from Jimma University Teaching Hospital) exposed infants and children who fulfilled the inclusion criteria were included. These two hospitals were purposively selected based on road accessibility, long and continuous followup of pediatric ART treatment status and availability of long Early Infant Diagnosis (EID) services.
Data collection procedure:
Data were collected by trained data collectors from registration books and computer data bases using checklist containing items on socio-demographic characteristics of parents/caregivers, HIV status, treatment status (ART initiation, dropout and adherence status), mortality status and turnaround time. Five in-depth interviews were conducted using unstructured interview guide with with purposively selected key informants from two hospitals (physician and nurse) and a laboratory technologist working at a regional laboratory. Data processing and analysis: The data were edited and entered in to Epi-data version 3.1 for double entry verification and then transported to SPSS version 16.0 for windows for analysis. The findings were presented using frequency tables and p-values of chi-square tests. Mean and standard deviation were used to present findings of continuous variables. Thematic analysis was done for qualitative data and qualitative findings were triangulated with quantitative findings. Pvalues less than 0.05 were taken as statistical association between variables.
Operational definitions:
The following operational definitions were used in this study. Treatment success: Initiation and continuation of HAART, improvement in CD4 count from the baseline, improvement in HIV WHO staging as per the WHO guideline for pediatric HIV treatment Treatment adherence: Treatment retention (appointment to visit health institution to take medication) and compliance with medication doses (missing not more than three of the prescribed doses for 1 month prior to the study) Dropouts: Lost to found after initiation of HAART from the two hospitals Turnaround time: The date from DBS sample collection of HIV-exposed infants and children from two hospitals to the date when HIV screening results from Regional Laboratory were received by two hospitals HIV exposure: Infants and children who were registered as "HIV-exposed infant and child" by two hospitals Apparently healthy mother: The HIV positive mother with no recognizable clinical symptoms of HIV.
Ethical considerations
Ethical clearance was secured from the Institutional Review Board (IRB) of Jimma University (JU), College of Health Sciences to conduct the study in the specified area. Letter of permission was obtained from JU to communicate with and get permission from hospital managers. The respondents' identities were kept confidential by avoiding identifiers. Written informed consent was obtained from hospital administrative bodies to get permission to take information from registration books. Consent was also obtained from the key informants.
RESULTS
Socio-demographic characteristics of care givers of HIV-exposed infants and children:
One hundred and thirty eight HIV-exposed infants and children in both hospitals were tested for against HIV infection by DNA/PCR. Data of 138 HIV-exposed infants and children and their parents' socio-demographic characteristics were collected. The results indicated that 136(98.6%) caregivers of the HIV-exposed infants and children were biological parents out of which 130(94.2%) were females. One hundred and eleven (80.4%) caregivers were in the age range of 17 to 35 years, 23(16.7%) were 36 to 49 years old while 4(2.9%) were ≥50 years old with the mean age of 30.2(SD=7.3) years (Table 1) .
The study also depicted that 103(74.6%) of the caregivers were married, 13(9.4%) were single, 9(6.5%) were divorced and 12(8.7%) were widowed. Sixty-nine (50.0%) caregivers were illiterate, 10(7.2%) could read and write, 37(26.8%) while 17(12.3%) were at primary and secondary educational level respectively. Ninetyfour (68.1%) of the caregivers had five and below family members while 44(31.9) of them had above five families members with average family size of 4.55 (Table 1) .
The finding of the study also indicated that 104(74.5%) mothers initiated ART, while they were pregnant with index child. PMTCT service was provided to 81(58.7%) mothers while they were pregnant with index child. One hundred and sixteen (84.1%) mothers were apparently healthy before and during data collection period (Table 1) . HIV status of HIV exposed infants and children: Data were collected on 138 HIVexposed infants and children of which 67(48.6%) and 71(51.4%) were males and females. From 138 HIV-exposed infants and children, 98(71%) of them were diagnosed for HIV infection by DNA/PCR. From infants and children diagnosed with HIV,48(49.0%) and 50(51.0%) were males and females respectively. Seventy-two (52.2%), 59(42.8%) and 7(5.0%) HIV-exposed infants and children were below 6 months old, 7-12 months old and 13-18 months old respectively. The mean age of HIV-exposed infants and children was 7.6 (SD=3. 8) months. Thirty-seven (37.8%), 54(55.1%) and 7(71.5%) of the HIV positive infants and children were below 6, 7-12 and 13-18 months old respectively.
Ethiop Fifty-three (64.1%) HIV-exposed infants and children born from 81(58.7%) mothers provided with PMTCT service were infected with HIV virus. Seventeen (60.7%) HIV-exposed infants and children born from 29(20.3%) mothers with no PMTCT service were infected with HIV virus, while 28(96.6%) HIV-exposed infants and children born from 29(21.3%) mothers with unknown PMTCT service status were infected with HIV virus. The association between the PMTCT service and HIV infection status of infants and children indicated that there was a significant difference among HIV-exposed infants and children in acquiring HIV infection from their mothers depending on PMTCT service status of the mothers during pregnancy (p-value=0.003) ( Table 3) .
ART initiation, dropout/adherence and mortality status of HIV diagnosed infants and children:
The study indicated that of the infants and children diagnosed to have HIV infection, 68(69.4%) initiated ART treatment ( Table  3 ). The study indicated that of the infants and children who initiated ART treatments, 34(50.0%) dropped from ART treatment ( Table 2 ). The association between the PMTCT service and dropping from ART treatment indicated a significant difference in dropping from ART among infants and children who initiated ART based on PMTCT service status of the mothers during pregnancy (p-value=0.002) ( Table 3) .
The study also indicated that of the infants and children who initiated ART, 28(80%) adhered to ART. Eleven (16.18%) of the infants and children died after they had initiated ART. The association between the PMTCT service and death after ART was initiated indicated significant difference in death among infants and children who initiated ART based on PMTCT service status of their mothers during pregnancy (pvalue=0.010) ( Table 2 ). 
DISCUSSION
This study determined the HIV infection status, dropout, adherence rates and turnaround time among HIV-exposed infants and children. In 2010, in the region where this study was conducted, HIV-positive pregnant women were estimated to be 23,940. From these, annually 3,861 infants were expected to be born with the virus. Focusing on testing efforts only on those known HIVexposed infants and children may result in missed opportunities of HIV screening for truly HIVexposed infants and children (4) (5) (6) (7) .
This study indicated that 57(42.0%) of mothers of the infants and children did not take PMTCT. This might be due to lack of awareness among mothers about their HIV status during pregnancy of the index child. This can imply great risk for fetus to acquire HIV infection for mothers who had no ANC followup and did not know their HIV status. HIV-infected mothers who were aware of their own HIV status might not shared their HIV status to pediatric providers (5) (6) (7) (8) .
Fifty-three (64.1%) HIV-exposed infants and children born from 81(58.7%) mothers provided with PMTCT service were infected with HIV virus. Seventeen (60.7%) HIV-exposed infants and children born from 29(20.3%) mothers with no PMTCT service were infected with HIV virus, while 28(96.6%) HIV-exposed infants and children born from 29(21.3%) mothers with unknown PMTCT service status were infected with HIV virus. The association between the PMTCT service and HIV status of infant and child indicated that there was a significant difference among HIV-exposed infants and children in acquiring HIV infection from their mother depending on PMTCT service status of the mothers during pregnancy (p-value=0.003). Strategies to improve linkage between PMTCT and pediatric records like child health cards indicating maternal HIV status (9) and integrated maternal and child health programs (10, 11) are important. If there are no such efforts, many infants and children whose mothers are unaware of their own HIV infections can be missed.
The study indicated that of 98(71%) infants and children diagnosed HIV-positive by DNA/PCR, ART was initiated for 68 (69.4%) infants and children. This figure is far higher than the findings in Botswana (12), Tanzania (13) and Malawi (14) , which indicated ART was initiated for 45%, 46% and 55% infants and children with HIV respectively. These differences could be explained by the difference in hospital enrolment rate of infants and children for ART initiation, the study settings and the study samples. The study indicated that there was a significant difference among HIV-exposed infants and children in acquiring HIV infection (p-value=0.003), dropping from ART (p-value=0.002) and death after ART was initiated (p-value=0.010) based on PMTCT service status of their mothers. However, there was no significant difference among HIV-exposed infants and children in ART initiation (pvalue=0.802) and adherence to ART (pvalue=0.405) based on PMTCT service status of their mothers. These two findings could be explained by lack of HIV testing during pregnancy or false negative HIV antibody tests during acute maternal infection (15) or delayed ANC followup during pregnancy of the index child during the study period. These findings are also consistent with the findings of similar studies (12, 16, 17, 15, 18, 19) .
This study had some limitations. Several records were incomplete on required variables in data sources. The size of the study might not represent status of exposed and diagnosed infants and children of all Regional Laboratories in Ethiopia due to limited study sites which might lead to statistical uncertainty. Another limitation of the study was that infants' and children's adherence to treatment through both hospitals was determined using records completed by health providers based on the information provided by mothers of infants and children, and by searching the followup compliance of infants based on their appointment dates. The information gathered from mothers of infants and children might have affected the validity of the study. This might in turn overestimate or underestimate adherence to ART. If the caregivers of infants and children had been directly interviewed and if all clinical markers had been applied, information about treatment adherence would have been more accurate. This study might not also have captured the exposure status of all infants and children of all HIV-positive mothers during antenatal followup.
Despite the limitations explained above, this study identified some valuable facts on ART treatment status, mortality and turnaround time which provide an opportunity for further planning and evidence-based decision-making.
In conclusion, the overall turnaround was 10 days. There was a significant difference among HIV-exposed infants and children in acquiring HIV infection from their mothers and dropping from ART depending on PMTCT service status of the mothers during pregnancy. There was institutional and regional challenges on sample collection, transportation and processing. Successful reduction of new HIV infection during pregnancy, earlier HIV screening during pregnancy and provision of PMTCT service should be effected.
